NCT02780154View on ClinicalTrials.gov

PfSPZ Challenge in Non-immune Adults in Baltimore, USA

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 25, 2016

Primary Completion Date

December 15, 2016

Study Completion Date

December 15, 2016

Conditions
Plasmodium Falciparum Infection
Interventions
BIOLOGICAL

PfSPZ (7G8) Challenge

PfSPZ (7G8) is a candidate vaccine, it consists of a suspension of purified, live-attenuated cryopreserved Pf sporozoites in a cryoprotectant.

BIOLOGICAL

PfSPZ (NF54) Challenge

PfSPZ (NF54) is a candidate vaccine, it consists of a suspension of purified, live-attenuated cryopreserved Pf sporozoites in a cryoprotectant.

Trial Locations (1)

21201-1509

University of Maryland School of Medicine - Center for Vaccine Development - Baltimore, Baltimore

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT02780154 - PfSPZ Challenge in Non-immune Adults in Baltimore, USA | Biotech Hunter | Biotech Hunter